202 related articles for article (PubMed ID: 31235852)
1. SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness.
Nguyen CH; Glüxam T; Schlerka A; Bauer K; Grandits AM; Hackl H; Dovey O; Zöchbauer-Müller S; Cooper JL; Vassiliou GS; Stoiber D; Wieser R; Heller G
Sci Rep; 2019 Jun; 9(1):9139. PubMed ID: 31235852
[TBL] [Abstract][Full Text] [Related]
2. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia.
Du W; He J; Zhou W; Shu S; Li J; Liu W; Deng Y; Lu C; Lin S; Ma Y; He Y; Zheng J; Zhu J; Bai L; Li X; Yao J; Hu D; Gu S; Li H; Guo A; Huang S; Feng X; Hu D
J Transl Med; 2019 Jun; 17(1):191. PubMed ID: 31171000
[TBL] [Abstract][Full Text] [Related]
3. High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Laszlo GS; Ries RE; Gudgeon CJ; Harrington KH; Alonzo TA; Gerbing RB; Raimondi SC; Hirsch BA; Gamis AS; Meshinchi S; Walter RB
Leuk Lymphoma; 2014 Dec; 55(12):2817-21. PubMed ID: 24559289
[TBL] [Abstract][Full Text] [Related]
4. Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.
Kazi JU; Rönnstrand L
Mol Oncol; 2013 Jun; 7(3):693-703. PubMed ID: 23548639
[TBL] [Abstract][Full Text] [Related]
5. Molecular synergy underlies the co-occurrence patterns and phenotype of
Dovey OM; Cooper JL; Mupo A; Grove CS; Lynn C; Conte N; Andrews RM; Pacharne S; Tzelepis K; Vijayabaskar MS; Green P; Rad R; Arends M; Wright P; Yusa K; Bradley A; Varela I; Vassiliou GS
Blood; 2017 Oct; 130(17):1911-1922. PubMed ID: 28835438
[No Abstract] [Full Text] [Related]
6.
Nguyen CH; Schlerka A; Grandits AM; Koller E; van der Kouwe E; Vassiliou GS; Staber PB; Heller G; Wieser R
Cancer Res; 2020 Oct; 80(20):4527-4539. PubMed ID: 32873636
[TBL] [Abstract][Full Text] [Related]
7. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
[TBL] [Abstract][Full Text] [Related]
8. Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221.
Zhang R; Huo CH
Onco Targets Ther; 2020; 13():2925-2934. PubMed ID: 32308425
[TBL] [Abstract][Full Text] [Related]
9. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
10. SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias.
Vitali C; Bassani C; Chiodoni C; Fellini E; Guarnotta C; Miotti S; Sangaletti S; Fuligni F; De Cecco L; Piccaluga PP; Colombo MP; Tripodo C
Cancer Res; 2015 Jun; 75(11):2387-99. PubMed ID: 25858143
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.
Wang H; Li XQ; Chu TT; Han SY; Qi JQ; Tang YQ; Qiu HY; Fu CC; Tang XW; Ruan CG; Wu DP; Han Y
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2659-2670. PubMed ID: 33550446
[TBL] [Abstract][Full Text] [Related]
12. A Novel 85-Gene Expression Signature Predicts Unfavorable Prognosis in Acute Myeloid Leukemia.
Lai Y; Sheng L; Wang J; Zhou M; OuYang G
Technol Cancer Res Treat; 2021; 20():15330338211004933. PubMed ID: 33784904
[TBL] [Abstract][Full Text] [Related]
13. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
[TBL] [Abstract][Full Text] [Related]
14. PBX3 is essential for leukemia stem cell maintenance in MLL-rearranged leukemia.
Guo H; Chu Y; Wang L; Chen X; Chen Y; Cheng H; Zhang L; Zhou Y; Yang FC; Cheng T; Xu M; Zhang X; Zhou J; Yuan W
Int J Cancer; 2017 Jul; 141(2):324-335. PubMed ID: 28411381
[TBL] [Abstract][Full Text] [Related]
15. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
16. Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia.
Xu ZJ; Ma JC; Zhou JD; Wen XM; Yao DM; Zhang W; Ji RB; Wu DH; Tang LJ; Deng ZQ; Qian J; Lin J
J Transl Med; 2019 Mar; 17(1):102. PubMed ID: 30922328
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia.
Nguyen CH; Bauer K; Hackl H; Schlerka A; Koller E; Hladik A; Stoiber D; Zuber J; Staber PB; Hoelbl-Kovacic A; Purton LE; Grebien F; Wieser R
Cell Death Dis; 2019 Dec; 10(12):944. PubMed ID: 31822659
[TBL] [Abstract][Full Text] [Related]
18.
Nguyen CH; Grandits AM; Vassiliou GS; Staber PB; Heller G; Wieser R
Biomedicines; 2020 Sep; 8(10):. PubMed ID: 32998330
[No Abstract] [Full Text] [Related]
19. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
Duployez N; Marceau-Renaut A; Villenet C; Petit A; Rousseau A; Ng SWK; Paquet A; Gonzales F; Barthélémy A; Leprêtre F; Pottier N; Nelken B; Michel G; Baruchel A; Bertrand Y; Leverger G; Lapillonne H; Figeac M; Dick JE; Wang JCY; Preudhomme C; Cheok M
Leukemia; 2019 Feb; 33(2):348-357. PubMed ID: 30089916
[TBL] [Abstract][Full Text] [Related]
20. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]